Details
Stereochemistry | RACEMIC |
Molecular Formula | C24H30N2O4 |
Molecular Weight | 410.506 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)C=C(N(C)C2=O)C3=CC=C(OCC(O)CNC(C)(C)C)C=C3
InChI
InChIKey=MZELTXWHFDTAOO-UHFFFAOYSA-N
InChI=1S/C24H30N2O4/c1-24(2,3)25-14-18(27)15-30-19-9-6-16(7-10-19)22-12-17-8-11-20(29-5)13-21(17)23(28)26(22)4/h6-13,18,25,27H,14-15H2,1-5H3
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Radioligand binding studies with 3-(4-(2-hydroxy-3-((1, 1-dimethylethyl)-amino)-propoxy)-phenyl)-7-methoxy-2-methyl- 1(2H)-isoquinolinone (HI-42), a new cardioselective beta-adrenoceptor blocker with long-lasting effects in vivo. | 1985 |
|
The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. | 1987 Apr |
|
Beta-adrenoceptor-binding studies of the cardioselective beta blockers bisoprolol, H-I 42 BS, and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats: two beta 1-binding sites for bisoprolol. | 1990 Mar |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2883988
Single dose - 400 mg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1742429
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
K3B3L3Q0GV
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
67793-71-9
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
10070156
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
C65479
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
SUB06397MIG
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
DTXSID301024412
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
5869
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
126522-41-6
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
SUPERSEDED | |||
|
100000080817
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
Draquinolol
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY |
ACTIVE MOIETY